Physician profile
Mark L Wheeler
NPI 1326494568
$8,782.79
in general payments reported to CMS, 2019-2025
18 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $218 · 2021: $1,107 · 2022: $663 · 2023: $5,062 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,879 · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,879.09 |
| Food and Beverage | $306.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,328.87 | 2023-2025 | Ion, Da Vinci Surgical System |
| Pulmonx Corporation | $1,372.44 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,122.40 | 2023 | Na |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.52 | 2019-2022 | |
| Glaxosmithkline, LLC. | $172.11 | 2020-2025 | Arexvy, Trelegy Ellipta |
| Inspire Medical Systems, INC. | $105.58 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $99.40 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $75.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $68.60 | 2019-2022 | |
| Genentech USA, INC. | $45.17 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.96 | 2020-2021 | |
| Baxter Healthcare | $29.03 | 2022 | |
| Csl Behring | $28.02 | 2020 | |
| Advanced Respiratory, INC | $22.93 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.47 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $15.11 | 2021 | |
| Gilead Sciences, INC. | $14.64 | 2022 | |
| Harmony Biosciences LLC | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.